Related references
Note: Only part of the references are listed.Novel VHH-Based Tracers with Variable Plasma Half-Lives for Imaging of CAIX-Expressing Hypoxic Tumor Cells
Sanne A. M. van Lith et al.
MOLECULAR PHARMACEUTICS (2022)
A Microdosing Study with 99mTc-PHC-102 for the SPECT/CT Imaging of Primary and Metastatic Lesions in Renal Cell Carcinoma Patients
Oana C. Kulterer et al.
JOURNAL OF NUCLEAR MEDICINE (2021)
A novel 111indium-labeled dual carbonic anhydrase 9-targeted probe as a potential SPECT imaging radiotracer for detection of hypoxic colorectal cancer cells
Siao-Syun Guan et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2021)
Modulation of the Pharmacokinetics of a Radioligand Targeting Carbonic Anhydrase-IX with Albumin-Binding Moieties
Shimpei Iikuni et al.
MOLECULAR PHARMACEUTICS (2021)
Phase I study to assess safety, biodistribution and radiation dosimetry for 89Zr-girentuximab in patients with renal cell carcinoma
Robin I. J. Merkx et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)
Process validation, current good manufacturing practice production, dosimetry, and toxicity studies of the carbonic anhydrase IX imaging agent [111In]In-XYIMSR-01 for phase I regulatory approval
Ravindra A. De Silva et al.
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS (2021)
Synthesis and evaluation of 68Ga-labeled imidazothiadiazole sulfonamide derivatives for PET imaging of carbonic anhydrase-IX
Kazuma Nakashima et al.
NUCLEAR MEDICINE AND BIOLOGY (2021)
Imaging carbonic anhydrase IX as a method for monitoring hypoxia-related radioresistance in preclinical head and neck cancer models
Fokko J. Huizing et al.
PHYSICS & IMAGING IN RADIATION ONCOLOGY (2021)
Development of a 68Ga-labelled PET tracer for carbonic anhydrase IX-overexpressed tumors using the artificial sweetener saccharin
Un Chul Shin et al.
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS (2021)
In vivo three-dimensional evaluation of tumour hypoxia in nasopharyngeal carcinomas using FMT-CT and MSOT
Wenhui Huang et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2020)
Synthesis and evaluation of indium-111-labeled imidazothiadiazole sulfonamide derivative for single photon emission computed tomography imaging targeting carbonic anhydrase-IX
Shimpei Iikuni et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2020)
How and Why Are Cancers Acidic? Carbonic Anhydrase IX and the Homeostatic Control of Tumour Extracellular pH
Shen-Han Lee et al.
CANCERS (2020)
PET imaging and pharmacological therapy targeting carbonic anhydrase-IX high-expressing tumors using US2 platform based on bivalent ureidosulfonamide
Shimpei Iikuni et al.
PLOS ONE (2020)
Synthesis and evaluation of novel technetium-99m-hydroxamamide complex based on imidazothiadiazole sulfonamide targeting carbonic anhydrase-IX for tumor imaging
Shimpei Iikuni et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2020)
Targeting CAIX with [64Cu]XYIMSR-06 Small Molecular Radiotracer Enables Noninvasive PET Imaging of Malignant Glioma in U87 MG Tumor Cell Xenograft Mice
Xianteng Yang et al.
MOLECULAR PHARMACEUTICS (2019)
Development of the 99mTc-Hydroxamamide Complex as a Probe Targeting Carbonic Anhydrase IX
Shimpei Iikuni et al.
MOLECULAR PHARMACEUTICS (2019)
Comparative evaluation of affibody- and antibody fragments-based CAIX imaging probes in mice bearing renal cell carcinoma xenografts
Javad Garousi et al.
SCIENTIFIC REPORTS (2019)
Fluorine-18 click radiosynthesis and microPET/CT evaluation of a small peptide-a potential PET probe for carbonic anhydrase IX
Lina Jia et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2019)
Quantitative Imaging of the Hypoxia-Related Marker CAIX in Head and Neck Squamous Cell Carcinoma Xenograft Models
Fokko J. Huizing et al.
MOLECULAR PHARMACEUTICS (2019)
A Flexible Synthesis of 68Ga-Labeled Carbonic Anhydrase IX (CAIX)-Targeted Molecules via CBT/1,2-Aminothiol Click Reaction
Kuo-Ting Chen et al.
MOLECULES (2019)
CAIX-targeting radiotracers for hypoxia imaging in head and neck cancer models
Fokko J. Huizing et al.
SCIENTIFIC REPORTS (2019)
Acetazolamide-based [F-18]-PET tracer: In vivo validation of carbonic anhydrase IX as a sole target for imaging of CA-IX expressing hypoxic solid tumors
Kunal N. More et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2018)
Evaluation of 99mTc-sulfonamide and sulfocoumarin derivatives for imaging carbonic anhydrase IX expression
Misaki Nakai et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2018)
Cancer radiotheranostics targeting carbonic anhydrase-IX with 111In- and 90Y-labeled ureidosulfonamide scaffold for SPECT imaging and radionuclide-based therapy
Shimpei Iikuni et al.
THERANOSTICS (2018)
Tumor-targeted Dual-modality Imaging to Improve Intraoperative Visualization of Clear Cell Renal Cell Carcinoma: A First in Man Study
Marlene C. Hekman et al.
THERANOSTICS (2018)
Carbonic Anhydrase IX-Targeted Near-Infrared Dye for Fluorescence Imaging of Hypoxic Tumors
Sakkarapalayam M. Mahalingam et al.
BIOCONJUGATE CHEMISTRY (2018)
Design, synthesis and evaluation of 18F-labeled cationic carbonic anhydrase IX inhibitors for PET imaging
Zhengxing Zhang et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2017)
Preclinical validation of In-111-girentuxiniab-F(ab')(2) as a tracer to image hypoxia related marker CAIX expression in head and neck cancer xenografts
Fokko J. Huizing et al.
RADIOTHERAPY AND ONCOLOGY (2017)
Sulfocoumarin-, Coumarin-, 4-Sulfamoylphenyl-Bearing Indazole-3-carboxamide Hybrids: Synthesis and Selective Inhibition of Tumor-Associated Carbonic Anhydrase Isozymes IX and XII
Srinivas Angapelly et al.
CHEMMEDCHEM (2017)
Hypoxia-Targeting Fluorescent Nanobodies for Optical Molecular Imaging of Pre-Invasive Breast Cancer
Aram S. A. van Brussel et al.
MOLECULAR IMAGING AND BIOLOGY (2016)
PET/CT imaging of renal cell carcinoma with 18F-VM4-037: a phase II pilot study
Baris Turkbey et al.
ABDOMINAL RADIOLOGY (2016)
Evaluation of Nonpeptidic Ligand Conjugates for SPECT Imaging of Hypoxic and Carbonic Anhydrase IX-Expressing Cancers
Peng-Cheng Lv et al.
BIOCONJUGATE CHEMISTRY (2016)
A 99mTc-Labeled Ligand of Carbonic Anhydrase IX Selectively Targets Renal Cell Carcinoma In Vivo
Nikolaus Krall et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
Comparative Evaluation of Affibody Molecules for Radionuclide Imaging of in Vivo Expression of Carbonic Anhydrase IX
Javad Garousi et al.
MOLECULAR PHARMACEUTICS (2016)
Evaluation of a Carbonic Anhydrase IX-Targeted Near-Infrared Dye for Fluorescence-Guided Surgery of Hypoxic Tumors
Peng-Cheng Lv et al.
MOLECULAR PHARMACEUTICS (2016)
PET Imaging of Carbonic Anhydrase IX Expression of HT-29 Tumor Xenograft Mice with 68Ga-Labeled Benzenesulfonamides
Joseph Lau et al.
MOLECULAR PHARMACEUTICS (2016)
[64Cu]XYIMSR-06: A dual-motif CAIX ligand for PET imaging of clear cell renal cell carcinoma
Il Minn et al.
ONCOTARGET (2016)
Saccharin: A lead compound for structure-based drug design of carbonic anhydrase IX inhibitors
Brian P. Mahon et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2015)
A review of performance of near-infrared fluorescence imaging devices used in clinical studies
B. Zhu et al.
BRITISH JOURNAL OF RADIOLOGY (2015)
Trimeric Radiofluorinated Sulfonamide Derivatives to Achieve In Vivo Selectivity for Carbonic Anhydrase IX-Targeted PET Imaging
Joseph Lau et al.
JOURNAL OF NUCLEAR MEDICINE (2015)
Radionuclide and Fluorescence Imaging of Clear Cell Renal Cell Carcinoma Using Dual Labeled Anti-Carbonic Anhydrase IX Antibody G250
Constantijn H. J. Muselaers et al.
JOURNAL OF UROLOGY (2015)
Dual-display of small molecules enables the discovery of ligand pairs and facilitates affinity maturation
Moreno Wichert et al.
NATURE CHEMISTRY (2015)
Hypoxia-induced carbonic anhydrase IX as a target for cancer therapy: From biology to clinical use
Jaromir Pastorek et al.
SEMINARS IN CANCER BIOLOGY (2015)
Imaging of carbonic anhydrase IX with an 111In-labeled dual-motif inhibitor
Xing Yang et al.
ONCOTARGET (2015)
A Small-Molecule Drug Conjugate for the Treatment of Carbonic Anhydrase IX Expressing Tumors
Nikolaus Krall et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2014)
Synthesis and evaluation of 18F-labeled carbonic anhydrase IX inhibitors for imaging with positron emission tomography
Jinhe Pan et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2014)
Discovery and Characterization of Novel Selective Inhibitors of Carbonic Anhydrase IX
Virginija Dudutiene et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Optical Imaging of Renal Cell Carcinoma with Anti-Carbonic Anhydrase IX Monoclonal Antibody Girentuximab
Constantijn H. J. Muselaers et al.
JOURNAL OF NUCLEAR MEDICINE (2014)
A bivalent small molecule-drug conjugate directed against carbonic anhydrase IX can elicit complete tumour regression in mice
N. Krall et al.
CHEMICAL SCIENCE (2014)
Indium-111-labeled Girentuximab ImmunoSPECT as a Diagnostic Tool in Clear Cell Renal Cell Carcinoma
Constantijn H. J. Muselaers et al.
EUROPEAN UROLOGY (2013)
Dithiocarbamates strongly inhibit the β-class carbonic anhydrases from Mycobacterium tuberculosis
Alfonso Maresca et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2013)
Synthesis and SAR of Novel Re/99mTc-Labeled Benzenesulfonamide Carbonic Anhydrase IX Inhibitors for Molecular Imaging of Tumor Hypoxia
Genliang Lu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Screening of a Novel Peptide Targeting the Proteoglycan-Like Region of Human Carbonic Anhydrase IX
Shoaib Rana et al.
MOLECULAR IMAGING (2013)
Synthesis and evaluation of near-infrared fluorescent sulfonamide derivatives for imaging of hypoxia-induced carbonic anhydrase IX expression in tumors
Kevin Groves et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
Binding of the Phage Display Derived Peptide CaIX-P1 on Human Colorectal Carcinoma Cells Correlates with the Expression of Carbonic Anhydrase IX
Vasileios Askoxylakis et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2012)
Dithiocarbamates Strongly Inhibit Carbonic Anhydrases and Show Antiglaucoma Action in Vivo
Fabrizio Carta et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Optimization of a Novel Peptide Ligand Targeting Human Carbonic Anhydrase IX
Shoaib Rana et al.
PLOS ONE (2012)
In Vivo Imaging and Quantification of Carbonic Anhydrase IX Expression as an Endogenous Biomarker of Tumor Hypoxia
Bagna Bao et al.
PLOS ONE (2012)
Interfering with pH regulation in tumours as a therapeutic strategy
Dario Neri et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Carbonic Anhydrase IX in Renal Cell Carcinoma: Implications for Prognosis, Diagnosis, and Therapy
Alexander B. Stillebroer et al.
EUROPEAN UROLOGY (2010)
PET of Hypoxia with 89Zr-Labeled cG250-F(ab′)2 in Head and Neck Tumors
Bianca A. W. Hoeben et al.
JOURNAL OF NUCLEAR MEDICINE (2010)
Synthesis and biological evaluation of a 99mTc-labelled sulfonamide conjugate for in vivo visualization of carbonic anhydrase IX expression in tumor hypoxia
Vamsidhar Akurathi et al.
NUCLEAR MEDICINE AND BIOLOGY (2010)
A New Peptide Ligand for Targeting Human Carbonic Anhydrase IX, Identified through the Phage Display Technology
Vasileios Askoxylakis et al.
PLOS ONE (2010)
In vivo targeting of tumor-associated carbonic anhydrases using acetazolamide derivatives
Julia K. J. Ahlskog et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Imaging of CA IX with fluorescent labelled sulfonamides distinguishes hypoxic and (re)-oxygenated cells in a xenograft tumour model
Ludwig Dubois et al.
RADIOTHERAPY AND ONCOLOGY (2009)
Carbonic anhydrase inhibitors: Interactions of phenols with the 12 catalytically active mammalian isoforms (CA I-XIV)
Alessio Innocenti et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
Tumor-associated carbonic anhydrase 9 spatially coordinates intracellular pH in three-dimensional multicellular growths
Pawel Swietach et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Preoperative characterisation of clear-cell renal carcinoma using iodine-124-labelled antibody chimeric G250 (I-124-cG250) and PET in patients with renal masses: a phase I trial
Chaitanya R. Divgi et al.
LANCET ONCOLOGY (2007)
Carbonic anhydrase inhibitors.: Design of fluorescent sulfonamides as probes of tumor-associated carbonic anhydrase IX that inhibit isozyme IX-mediated acidification of hypoxic tumors
A Cecchi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Hypoxia activates the capacity of tumor-associated carbonic anhydrase IX to acidify extracellular pH
E Svastová et al.
FEBS LETTERS (2004)
Share Paper
